Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Küçükyurt, S., Kelezoğlu, A., Elverdi, T., Özmen, D., Ar, M. C., & Eşkazan, A. E. (2023). Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis. Hematology, Transfusion and Cell Therapy, 45(2), 275–277. https://doi.org/10.1016/j.htct.2021.04.007